Eiger BioPharmaceuticals, Inc.

  1. April 03, 2024

    Biotech Eiger Can Take Sentynl's Improved Drug Bid In Ch. 11

    Eiger BioPharmaceuticals Inc. received approval Wednesday to select a $30 million base offer for its Zokinvy drug and use cash collateral after a Texas bankruptcy judge dismissed objections to the relief, allowing the company to move ahead with a planned auction for its rare-disease treatments.

  2. April 01, 2024

    Eiger BioPharmaceuticals Hits Ch. 11 With $53.1M Debt

    Eiger BioPharmaceuticals Inc. filed for Chapter 11 protection in Texas bankruptcy court Monday with $53.1 million of debt and plans to sell its assets during the case.